JPS5867667A - 1−置換−4−フエニル−イソニコペチン酸エステル - Google Patents
1−置換−4−フエニル−イソニコペチン酸エステルInfo
- Publication number
- JPS5867667A JPS5867667A JP16670181A JP16670181A JPS5867667A JP S5867667 A JPS5867667 A JP S5867667A JP 16670181 A JP16670181 A JP 16670181A JP 16670181 A JP16670181 A JP 16670181A JP S5867667 A JPS5867667 A JP S5867667A
- Authority
- JP
- Japan
- Prior art keywords
- substituted
- phenyl
- acid ester
- isonicopetinic
- piperidino
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000002148 esters Chemical class 0.000 title claims description 12
- 239000002253 acid Substances 0.000 title description 12
- 125000001539 acetonyl group Chemical group [H]C([H])([H])C(=O)C([H])([H])* 0.000 claims description 2
- 125000000217 alkyl group Chemical group 0.000 claims description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- -1 3-piperidino-2-hydroxypropyl Chemical group 0.000 description 4
- 230000000202 analgesic effect Effects 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 125000004494 ethyl ester group Chemical group 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical class [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 230000003444 anaesthetic effect Effects 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 3
- 229910052742 iron Inorganic materials 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 206010002091 Anaesthesia Diseases 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 230000037005 anaesthesia Effects 0.000 description 2
- 238000000921 elemental analysis Methods 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- YWRXDGYUFPGSDH-MDZDMXLPSA-N (e)-n-methyl-n-[(1-methylindol-2-yl)methyl]-3-(5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)prop-2-enamide Chemical compound N1CCCC2=CC(/C=C/C(=O)N(CC=3N(C4=CC=CC=C4C=3)C)C)=CN=C21 YWRXDGYUFPGSDH-MDZDMXLPSA-N 0.000 description 1
- OYIFRKXKKNJLNN-UHFFFAOYSA-N 1-(oxiren-2-ylmethyl)piperidine Chemical group C=1OC=1CN1CCCCC1 OYIFRKXKKNJLNN-UHFFFAOYSA-N 0.000 description 1
- 241000143060 Americamysis bahia Species 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 206010015946 Eye irritation Diseases 0.000 description 1
- NIPNSKYNPDTRPC-UHFFFAOYSA-N N-[2-oxo-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 NIPNSKYNPDTRPC-UHFFFAOYSA-N 0.000 description 1
- 241000283977 Oryctolagus Species 0.000 description 1
- 241000270666 Testudines Species 0.000 description 1
- 238000006136 alcoholysis reaction Methods 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- BULLHNJGPPOUOX-UHFFFAOYSA-N chloroacetone Chemical compound CC(=O)CCl BULLHNJGPPOUOX-UHFFFAOYSA-N 0.000 description 1
- 239000004020 conductor Substances 0.000 description 1
- 210000004087 cornea Anatomy 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- PSLIMVZEAPALCD-UHFFFAOYSA-N ethanol;ethoxyethane Chemical compound CCO.CCOCC PSLIMVZEAPALCD-UHFFFAOYSA-N 0.000 description 1
- 231100000013 eye irritation Toxicity 0.000 description 1
- 230000000193 eyeblink Effects 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 1
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000003589 local anesthetic agent Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 150000002736 metal compounds Chemical class 0.000 description 1
- SUSQOBVLVYHIEX-UHFFFAOYSA-N phenylacetonitrile Chemical compound N#CCC1=CC=CC=C1 SUSQOBVLVYHIEX-UHFFFAOYSA-N 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 210000001747 pupil Anatomy 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 230000036647 reaction Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 125000005270 trialkylamine group Chemical group 0.000 description 1
Landscapes
- Epoxy Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP16670181A JPS5867667A (ja) | 1981-10-19 | 1981-10-19 | 1−置換−4−フエニル−イソニコペチン酸エステル |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP16670181A JPS5867667A (ja) | 1981-10-19 | 1981-10-19 | 1−置換−4−フエニル−イソニコペチン酸エステル |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5867667A true JPS5867667A (ja) | 1983-04-22 |
| JPS6361940B2 JPS6361940B2 (de) | 1988-11-30 |
Family
ID=15836142
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP16670181A Granted JPS5867667A (ja) | 1981-10-19 | 1981-10-19 | 1−置換−4−フエニル−イソニコペチン酸エステル |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS5867667A (de) |
-
1981
- 1981-10-19 JP JP16670181A patent/JPS5867667A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS6361940B2 (de) | 1988-11-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA1256878A (en) | Benzimidazol derivatives and their production | |
| JPH082871B2 (ja) | ピペラジニルカンファースルフォニルオキシトシン拮抗物質の置換アミン誘導体 | |
| DE2011806A1 (de) | Neue trieyclisehe Verbindungen | |
| JPH0557983B2 (de) | ||
| JPH03141258A (ja) | 新規なピペラジン誘導体 | |
| JPH0291052A (ja) | 置換アミン類 | |
| JPH033669B2 (de) | ||
| JPH0699307B2 (ja) | 抗痴呆剤 | |
| JPS60174781A (ja) | 強心および抗高血圧オキサジアジノン化合物 | |
| JPS58146566A (ja) | ピリジン誘導体 | |
| JPS58180484A (ja) | 1−置換N−/8α−エルゴリニル/−N′,N′−ジエチルウレア及びその製造方法 | |
| JPS6354363A (ja) | キノリン誘導体 | |
| JP2777661B2 (ja) | ベンゾヘテロ環化合物 | |
| JP2640953B2 (ja) | 芳香族複素環化合物 | |
| ELDERFIELD et al. | THE VON BRAUN CYANOGEN BROMIDE REACTION. II. APPLICATION TO N-ARYLPYRROLIDINES1, 2 | |
| CA1025865A (fr) | Procedes de preparation de nouvelles amides heterocycliques | |
| US3743646A (en) | Amides of 3-(2-halophenyl-5-tetrazolyl)propionic acids | |
| JPS6144873A (ja) | ピリダジノン誘導体またはその塩類 | |
| JPS59501715A (ja) | ピリジル−アセチルグアニジン | |
| JPS5946281A (ja) | 1置換ピロリチジン誘導体およびその用途 | |
| JPS60226877A (ja) | ピペリジン誘導体 | |
| JP3639326B2 (ja) | 新規なアコニチン型化合物及び鎮痛・抗炎症剤 | |
| JPS60149567A (ja) | 新規なイミダゾ−ル誘導体およびその製法 | |
| JPS6026797B2 (ja) | 新規なカルボスチリル誘導体 | |
| JPS6361940B2 (de) |